A Sydney tech entrepreneur turned to artificial intelligence, including ChatGPT, to develop a personalized cancer vaccine for his dog, Rosie, after conventional treatments proved insufficient. The remarkable case, involving a staffy-shar pei mix diagnosed with aggressive mast cell cancer, has stunned researchers and offers a glimpse into the potential of AI in veterinary and potentially human medicine.
Rosie’s journey began in 2019 when Paul Conyngham adopted her from a local animal shelter. After a diagnosis of advanced mast cell cancer in 2024, standard chemotherapy and surgery managed to slow the disease’s progression but failed to shrink the tumors. Faced with a grim prognosis, Conyngham, a data scientist and machine learning engineer with 17 years of experience, embarked on an unconventional path, leveraging his expertise to explore alternative treatment options. The core of his approach was to use AI to analyze Rosie’s genetic data and design a custom mRNA vaccine.
Conyngham invested $3,000 to have Rosie’s healthy DNA and tumor DNA sequenced at the University of Modern South Wales. He then utilized AI tools, including AlphaFold, a protein-modeling system, to pinpoint the specific mutations driving her cancer and identify potential drug targets. “We took her tumor, sequenced the DNA, we converted it from tissue to data, and we used that to find the problem in her DNA and then develop a cure based off that,” Conyngham told Australia’s Today Demonstrate. “ChatGPT assisted throughout the entire process.”
The Roadblock and the mRNA Solution
A significant hurdle arose when a pharmaceutical company refused to provide a promising immunotherapy drug for compassionate use. Undeterred, Conyngham collaborated with UNSW’s RNA Institute to manufacture a custom mRNA vaccine based on the AI-generated formula. This innovative approach drew the attention of the UNSW Ramaciotti Centre for Genomics, where researchers were initially surprised by the request. Associate Professor Smith noted that while the center receives unusual requests, this one stood out, as sequencing the DNA allows for mapping the tumor and identifying the mutations driving the cancer according to reports.
The results have been striking. A tennis ball-sized tumor on Rosie’s hock has reportedly halved since the custom mRNA vaccine was administered over the Christmas break, leaving researchers amazed at the treatment’s potential. The origins of mRNA research were initially focused on cancer treatment, highlighting the potential for this technology to revolutionize the field as noted on Reddit.
Implications for Cancer Treatment
This case demonstrates the potential of combining AI and genomic data to create personalized cancer treatments. While still experimental, the success with Rosie has sparked interest in applying similar approaches to human cancer therapy. The ability to rapidly analyze tumor DNA and design targeted vaccines could significantly improve treatment outcomes and reduce the reliance on traditional, often less effective, methods.
The story also highlights the challenges patients and their families face when seeking access to innovative treatments. The initial refusal of the pharmaceutical company to provide the immunotherapy drug underscores the need for more flexible compassionate use programs and greater access to cutting-edge therapies.
What comes next for Rosie and the broader field of AI-driven cancer treatment remains to be seen. Further research and clinical trials will be crucial to validate the effectiveness and safety of this approach. However, Rosie’s story offers a beacon of hope and a compelling example of how technology can be harnessed to improve the lives of both animals and humans.
Share your thoughts on this groundbreaking story in the comments below.
